BeyondSpring BYSI
NASDAQ BYSI
$0.72 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Other Accumulated Expenses (2015 - 2026)

BeyondSpring (BYSI) posted Other Accumulated Expenses of $937000.0 for Q1 2026, up 13.99% sequentially from $822000.0 in Q4 2025, and down 31.3% YoY from $1.4 million in Q1 2025.

BeyondSpring (BYSI) Other Accumulated Expenses (2015 - 2026) Analysis & Trends

BeyondSpring has reported Other Accumulated Expenses for 12 years, with the latest figure at $937000.0 in Q1 2026.

  • Quarterly Other Accumulated Expenses fell 31.3% year-over-year to $937000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $937000.0 (down 31.3% YoY) and the FY2025 annual result came in at $822000.0, up 5.38% from the prior year.
  • Other Accumulated Expenses climbed to $937000.0 in Q1 2026 per BYSI's latest filing, from $822000.0 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $5.1 million in Q2 2022 and troughed at $612000.0 in Q2 2025.
  • A 5-year average of $1.4 million and a median of $1.1 million in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses jumped 59.57% in 2022, then sank 78.28% in 2023.
  • Over 5 years, Other Accumulated Expenses stood at $1.5 million in 2022, then decreased by 27.96% to $1.1 million in 2023, then dropped by 27.03% to $780000.0 in 2024, then grew by 5.38% to $822000.0 in 2025, then advanced by 13.99% to $937000.0 in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $937000.0, $822000.0, and $676000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BeyondSpring 29.85 Mn 29.85 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Mn
Mar 31, 2026 937,000.00
Dec 31, 2025 822,000.00
Sep 30, 2025 676,000.00
Jun 30, 2025 612,000.00
Mar 31, 2025 1.36 Mn
Dec 31, 2024 780,000.00
Jun 30, 2024 1.64 Mn
Dec 31, 2023 1.07 Mn
Jun 30, 2023 1.10 Mn
Dec 31, 2022 1.48 Mn
Jun 30, 2022 5.08 Mn
Dec 31, 2021 6.17 Mn
Sep 30, 2021 5.77 Mn
Jun 30, 2021 3.19 Mn
Mar 31, 2021 1.92 Mn
Dec 31, 2020 3.81 Mn
Sep 30, 2020 1.55 Mn
Jun 30, 2020 1.46 Mn
Mar 31, 2020 1.69 Mn